Cite this article as: Caklili OT, Metli K, Basmaz SE, Kurt AMO, Yesilyurt A. CHEK2 mutation with heterozygote c.592+3A>T variant in a patient with early breast and papillary thyroid cancer. Endocrinol Res Pract. 2025;29(3):283-284.
Department of Endocrinology and Metabolism, Kocaeli City Hospital, Kocaeli, Türkiye
2.Department of Genetics, Kocaeli City Hospital, Kocaeli, Türkiye
3.Labgen Genetic Diagnosis Centre, Acıbadem Hospital Group, İstanbul, Türkiye
Cite this article as: Caklili OT, Metli K, Basmaz SE, Kurt AMO, Yesilyurt A. CHEK2 mutation with heterozygote c.592+3A>T variant in a patient with early breast and papillary thyroid cancer. Endocrinol Res Pract. 2025;29(3):283-284.